MRDC Seeks Entrepreneurs to Bring Life-Saving Airway Devices to Market (Part 1)

The U.S. Army Medical Research and Development Command (MRDC) is calling on entrepreneurs to help commercialize two new airway surgical devices designed to enhance patient safety during complex procedures. Developed by military surgeons and engineers, these innovations address the critical need for improved airway management both on the battlefield and in civilian medical settings. The MRDC’s Office of Medical Technology Transfer (MTT) aims to license these technologies to small businesses through its Assistive Technology Transfer (AT2) program.

One of the devices, developed by Dr. Corinne Nawn and Dr. Brian Souhan, uses light-based technology to ensure accurate placement of an endotracheal tube. Their system features a pinpoint light emitter and a photosensitive element on the breathing tube, which analyzes reflected light patterns from inside the trachea. The device signals proper placement with a green light and indicates misalignment by switching to red. The innovation could prove especially valuable in high-stress environments like ambulances and military evacuation helicopters, where airway dislodgement is a common risk.

The development of this light-based guidance system was made possible through collaboration between Nawn and Souhan, who were introduced by Col. Robert Carter. Drawing on expertise in photonics and biomedical engineering, the duo created a reflectivity map of the human trachea using hyperspectral imaging. This foundational data underpins the device’s ability to detect tissue types based on light absorption, offering a new layer of safety in airway management.

Another solution, created by Maj. Joshua Stramiello, addresses the challenges of performing tracheotomies. His design consists of a two-piece expandable tube, with a permanent outer guide and interchangeable inner tubes of varying diameters. This configuration simplifies the process of changing tubes, reducing the risk of misplacement and injury. Initially built using 3D modeling and printing in his spare time, Stramiello’s prototype has attracted attention within the Defense Health Agency and could have broad applications in both military and civilian settings.

The MTT, through its AT2 process, supports the transition of such technologies from concept to commercialization by connecting inventors with licensees and investors. The program has already brought over 30 biomedical innovations to market and reinvests royalty income into further development. By engaging frontline medical professionals in the innovation process, MRDC continues to advance medical tools that address real-world needs in trauma care.

Continued in Part 2…

Article by multiple RFHC contributors, based upon information from a press release by the U.S. Army Medical Research and Development Command

---